Surmodics Inc
SRDX26.790USD
+0.370+1.40%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
383.04MMarket Cap
LossP/E TTM
More Details of Surmodics Inc Company
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Surmodics Inc Info
Ticker SymbolSRDX
Company nameSurmodics Inc
IPO dateMar 04, 1998
CEOMr. Gary R. Maharaj
Number of employees389
Security typeOrdinary Share
Fiscal year-endMar 04
Address9924 W 74th St
CityEDEN PRAIRIE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code55344
Phone19525007000
Websitehttps://www.surmodics.com/
Ticker SymbolSRDX
IPO dateMar 04, 1998
CEOMr. Gary R. Maharaj
Company Executives of Surmodics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Mr. Jose H. Bedoya
Mr. Jose H. Bedoya
Independent Director
Independent Director
30.01K
+3.63%
Mr. Gordon S. Weber, J.D.
Mr. Gordon S. Weber, J.D.
Senior Vice President - Legal, General Counsel, Secretary
Senior Vice President - Legal, General Counsel, Secretary
21.04K
-1.49%
Ms. Lisa Wipperman Heine
Ms. Lisa Wipperman Heine
Independent Director
Independent Director
13.98K
+3.90%
Ms. Teryl L.W. Sides
Ms. Teryl L.W. Sides
Senior Vice President, President - Vascular Interventions
Senior Vice President, President - Vascular Interventions
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Other
70.52%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Other
70.52%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
39.31%
Investment Advisor
24.73%
Hedge Fund
22.33%
Research Firm
4.06%
Individual Investor
3.88%
Bank and Trust
0.51%
Sovereign Wealth Fund
0.22%
Pension Fund
0.09%
Insurance Company
0.03%
Other
4.84%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
312
12.95M
90.59%
-4.14M
2025Q2
321
12.64M
88.41%
-4.03M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
1.02M
7.13%
-27.06K
-2.58%
Jun 30, 2025
AllianceBernstein L.P.
850.47K
5.95%
+1.12K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
810.18K
5.67%
+11.51K
+1.44%
Jun 30, 2025
Soleus Capital Management, L.P.
789.06K
5.52%
--
--
Jun 30, 2025
Gabelli Funds, LLC
745.83K
5.22%
+26.83K
+3.73%
Jun 30, 2025
Trium Capital LLP
716.78K
5.01%
+716.78K
--
Jul 11, 2025
UBS Financial Services, Inc.
422.72K
2.96%
+356.98K
+543.00%
Jun 30, 2025
Hudson Bay Capital Management LP
400.00K
2.8%
-64.97K
-13.97%
Jun 30, 2025
Qube Research & Technologies Ltd
393.98K
2.76%
+4.80K
+1.23%
Jun 30, 2025
Readystate Asset Management LP
433.61K
3.03%
+433.61K
--
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
First Trust Merger Arbitrage ETF
4.36%
SPDR S&P Health Care Equipment ETF
0.45%
Inspire Small/Mid Cap ESG ETF
0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
iShares Micro-Cap ETF
0.08%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
ProShares Hedge Replication ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.02%
View more
First Trust Merger Arbitrage ETF
Proportion4.36%
SPDR S&P Health Care Equipment ETF
Proportion0.45%
Inspire Small/Mid Cap ESG ETF
Proportion0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.08%
iShares Micro-Cap ETF
Proportion0.08%
iShares U.S. Medical Devices ETF
Proportion0.05%
Franklin US Small Cap Multifactor Index ETF
Proportion0.05%
iShares Russell 2000 Growth ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
